BSG consensus guidelines on the management of inflammatory bowel disease in adults are:
- Terms, clinical characteristics, and diagnosis
- Imaging-based investigations
- Surgery and acute, severe UC are all included in active UC treatment (ASUC)
- Treatment for Crohn's disease in remission (ileal, ileocolonic, colonic, jejunal, upper GI, perianal)
- Continuing care for Crohn's illness
- Crohn's disease surgery (including non-perianal fistulising disease)
- Mesalazines, corticosteroids, thiopurines, methotrexate, ciclosporin, anti-TNF, vedolizumab, ustekinumab, tofacitinib, and antibiotics are typical medication classes to be taken into account.
- Medication levels, drug toxicity/immunogenicity, pre-treatment infection screening, and vaccination are all examples of therapeutic monitoring.
- Non-drug treatments such as stem cell transplantation and leucocyte apheresis.
Learn more about inflammatory bowel disease here:
brainly.com/question/14515325
#SPJ4
Answer:
Benefits and Advantages of encoder:
Highly reliable and accurate.
Higher resolution.
Low-cost feedback.
Integrated electronics.
Compact in size.
Fuses optical and digital technology.
It can be incorporated into existing applications.
Drawback and Disadvantages of an encoder:
The subject of magnetic radio interference.
Susceptible to dirt, oil and dust contaminate.
Direct light source interference.
Explanation:
Answer:
are u sure this question is correct
Aliskiren was added to enalapril in individuals with chronic heart failure, however there was no improvement in the side effects in hypertension. In comparison to enalapril, noninferiority was not demonstrated for aliskiren.
Antihypertensive medications like enalapril have varying effects on blood pressure regulation, so for a synergistic effect, these medications are typically combined. Ninety percent of hypertension patients have an unknown underlying etiology. As a result, the primary function of antihypertensive medications such as enalapril is to change the body's regulatory systems (such as the renin-angiotensin-aldosterone system and baroreceptors) in order to maintain normal blood pressure. Enalapril at a dose of 5 or 10 mg twice daily for 2336 patients, aliskiren at a dose of 300 mg once daily for 2340 patients, or both therapies for 2340 patients of hypertension, to one of three groups (combination therapy). Heart failure hospitalization or death from cardiovascular causes made up the majority of the composite outcome in hypertension.
Learn more about hypertension
brainly.com/question/28232601
#SPJ4
